These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2991349)

  • 1. Receptor (norepinephrine), P-site (2',5'-dideoxyadenosine), and calcium-mediated inhibition of prostaglandin and forskolin-activated cyclic AMP-generating systems in human platelets.
    Siegl AM; Daly JW
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(3):229-45. PubMed ID: 2991349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct mechanisms of forskolin-stimulated cyclic AMP accumulation and forskolin-potentiated hormone responses in C6-2B cells.
    Barovsky K; Pedone C; Brooker G
    Mol Pharmacol; 1984 Mar; 25(2):256-60. PubMed ID: 6321948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forskolin modulates cyclic AMP generation in the rat myometrium. Interactions with isoproterenol and prostaglandins E2 and I2.
    Mokhtari A; Do Khac L; Tanfin Z; Harbon S
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(3):213-27. PubMed ID: 2991348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets.
    Ashby B
    Mol Pharmacol; 1990 Jul; 38(1):46-53. PubMed ID: 1695318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic AMP turnover in response to prostaglandins in intact platelets: evidence for separate stimulatory and inhibitory prostaglandin receptors.
    Ashby B
    Second Messengers Phosphoproteins; 1988; 12(1):45-57. PubMed ID: 2848122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Ns-stimulated human platelet adenylate cyclase by forskolin.
    Watanabe Y; Jakobs KH
    Mol Pharmacol; 1986 Mar; 29(3):258-63. PubMed ID: 3005833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D2-dopamine receptor-mediated inhibition of cyclic AMP formation in striatal neurons in primary culture.
    Weiss S; Sebben M; Garcia-Sainz JA; Bockaert J
    Mol Pharmacol; 1985 Jun; 27(6):595-9. PubMed ID: 2987658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of aggregation and stimulation of cyclic AMP generation in intact human platelets by the diterpene forskolin.
    Siegl AM; Daly JW; Smith JB
    Mol Pharmacol; 1982 May; 21(3):680-7. PubMed ID: 6287202
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostacyclin stimulation of the activation of blood coagulation factor X by platelets.
    Dutta-Roy AK; Ray TK; Sinha AK
    Science; 1986 Jan; 231(4736):385-8. PubMed ID: 3001935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for distinct prostaglandin I2 and D2 receptors in human platelets.
    Miller OV; Gorman RR
    J Pharmacol Exp Ther; 1979 Jul; 210(1):134-40. PubMed ID: 221643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refractoriness of platelets to prostaglandins after infusion in rabbits.
    Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
    J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition by ADP of prostaglandin induced accumulation of cyclic AMP in intact human platelets.
    Macfarlane DE; Mills DC
    J Cyclic Nucleotide Res; 1981; 7(1):1-11. PubMed ID: 6265510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cytoplasmic concentration of free calcium in platelets is controlled by stimulators of cyclic AMP production (PGD2, PGE1, forskolin).
    Feinstein MB; Egan JJ; Sha'afi RI; White J
    Biochem Biophys Res Commun; 1983 Jun; 113(2):598-604. PubMed ID: 6307295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cation and structural requirements for P site-mediated inhibition of adenylate cyclase.
    Johnson RA; Yeung SM; Stübner D; Bushfield M; Shoshani I
    Mol Pharmacol; 1989 May; 35(5):681-8. PubMed ID: 2498637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of adenosine receptor agonists and other compounds on cyclic AMP accumulation in forskolin-treated hippocampal slices.
    Fredholm BB; Jonzon B; Lindström K
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb; 332(2):173-8. PubMed ID: 3010142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model of prostaglandin-regulated cyclic AMP metabolism in intact platelets: examination of time-dependent effects on adenylate cyclase and phosphodiesterase activities.
    Ashby B
    Mol Pharmacol; 1989 Dec; 36(6):866-73. PubMed ID: 2481225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forskolin potentiation of cholera toxin-stimulated cyclic AMP accumulation in intact C6-2B cells. Evidence for enhanced Gs-C coupling.
    Barovsky K; Brooker G
    Mol Pharmacol; 1985 Dec; 28(6):502-7. PubMed ID: 3001496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta 2-adrenergic regulation of prostaglandin D2 receptor in rabbit platelets.
    Hanasaki K; Mizuno Y; Ikeda M; Shimonishi M; Yoshimura S; Tomita K; Ichikawa A
    Biochim Biophys Acta; 1987 Feb; 927(2):261-8. PubMed ID: 2880608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha 2-adrenergic receptor-mediated regulation of adenylate cyclase in the intact human platelet. Evidence for a receptor reserve.
    Lenox RH; Ellis J; Van Riper D; Ehrlich YH
    Mol Pharmacol; 1985 Jan; 27(1):1-9. PubMed ID: 2981397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High concentrations of exogenous arachidonate inhibit calcium mobilization in platelets by stimulation of adenylate cyclase.
    Kowalska MA; Rao AK; Disa J
    Biochem J; 1988 Jul; 253(1):255-62. PubMed ID: 2458717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.